Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

West Nile fever characteristics among viremic persons identified through blood donor screening.

Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL.

J Infect Dis. 2010 Nov 1;202(9):1354-61. doi: 10.1086/656602.

2.

Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening.

Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP.

Transfusion. 2009 Feb;49(2):278-88. doi: 10.1111/j.1537-2995.2008.01952.x.

PMID:
19389211
3.

Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors.

Orton SL, Stramer SL, Dodd RY.

Transfusion. 2006 Feb;46(2):272-7.

PMID:
16441606
4.

Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening.

Lai L, Lee TH, Tobler L, Wen L, Shi P, Alexander J, Ewing H, Busch M.

Transfusion. 2012 Feb;52(2):447-54. doi: 10.1111/j.1537-2995.2011.03289.x. Epub 2011 Aug 9.

PMID:
21827506
5.

West Nile virus blood transfusion-related infection despite nucleic acid testing.

Macedo de Oliveira A, Beecham BD, Montgomery SP, Lanciotti RS, Linnen JM, Giachetti C, Pietrelli LA, Stramer SL, Safranek TJ.

Transfusion. 2004 Dec;44(12):1695-9.

PMID:
15584982
6.

The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.

Kleinman S, Glynn SA, Busch M, Todd D, Powell L, Pietrelli L, Nemo G, Schreiber G, Bianco C, Katz L; NHLBI Retrovirus Epidemiology Study (REDS).

Transfusion. 2005 Apr;45(4):469-79.

PMID:
15819665
7.

West Nile virus among blood donors in the United States, 2003 and 2004.

Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY.

N Engl J Med. 2005 Aug 4;353(5):451-9.

8.

Detection of West Nile virus in blood donations--United States, 2003.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2003 Aug 15;52(32):769-72.

9.

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.

Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH.

N Engl J Med. 2005 Aug 4;353(5):460-7.

10.

Transmission of West Nile virus through blood transfusion in the United States in 2002.

Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland ME; West Nile Virus Transmission Investigation Team.

N Engl J Med. 2003 Sep 25;349(13):1236-45. Epub 2003 Sep 18.

11.

West Nile virus in Canadian blood donors.

Cameron C, Reeves J, Antonishyn N, Tilley P, Alport T, Eurich B, Towns D, Lane D, Saldanha J.

Transfusion. 2005 Apr;45(4):487-91.

PMID:
15819667
12.

Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.

Busch MP, Tobler LH, Saldanha J, Caglioti S, Shyamala V, Linnen JM, Gallarda J, Phelps B, Smith RI, Drebot M, Kleinman SH.

Transfusion. 2005 Apr;45(4):492-9.

PMID:
15819668
13.

Tregs control the development of symptomatic West Nile virus infection in humans and mice.

Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ.

J Clin Invest. 2009 Nov;119(11):3266-77. doi: 10.1172/JCI39387. Epub 2009 Oct 12.

14.

West Nile virus adheres to human red blood cells in whole blood.

Rios M, Daniel S, Chancey C, Hewlett IK, Stramer SL.

Clin Infect Dis. 2007 Jul 15;45(2):181-6. Epub 2007 Jun 12.

15.

Virus and antibody dynamics in acute west nile virus infection.

Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, Matud JL, Prince HE, Lanciotti RS, Wright DJ, Linnen JM, Caglioti S.

J Infect Dis. 2008 Oct 1;198(7):984-93. doi: 10.1086/591467.

16.

West Nile virus infections projected from blood donor screening data, United States, 2003.

Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, Prince HE, Bianco C, Foster G, Petersen LR, Nemo G, Glynn SA.

Emerg Infect Dis. 2006 Mar;12(3):395-402.

17.

A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus.

Biggerstaff BJ, Petersen LR.

Transfusion. 2009 Jun;49(6):1151-9. doi: 10.1111/j.1537-2995.2009.02112.x. Epub 2009 Feb 27.

PMID:
19309472
18.

Reacting to an emerging safety threat: West Nile virus in North America.

Stramer SL.

Dev Biol (Basel). 2007;127:43-58.

PMID:
17486880
19.

West Nile virus transmission via organ transplantation and blood transfusion - Louisiana, 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Nov 20;58(45):1263-7.

20.

West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing.

Kleinman SH, Williams JD, Robertson G, Caglioti S, Williams RC, Spizman R, Morgan L, Tomasulo P, Busch MP.

Transfusion. 2009 Jun;49(6):1160-70. doi: 10.1111/j.1537-2995.2009.02127.x. Epub 2009 Mar 20.

PMID:
19320866
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk